Tower Trust & Investment Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
4,757
-5
-0.1% -$1.17K 0.73% 26
2026
Q1
$1.16M Sell
4,762
-174
-4% -$40.5K 0.76% 30
2025
Q4
$1.02M Buy
4,936
+717
+17% +$142K 0.64% 38
2025
Q3
$782K Buy
4,219
+47
+1% +$8.05K 0.53% 47
2025
Q2
$637K Buy
4,172
+3,825
+1,102% +$588K 0.45% 63
2025
Q1
$54.2K Buy
+347
New +$54.3K 0.04% 115

Other funds holding JNJ

Tower Trust & Investment Company's JNJ Position: Q2 2026 in Review

Tower Trust & Investment Company reduced its Johnson & Johnson (JNJ) stake by 0.1% in Q2 2026, selling an estimated $1.17K and leaving 4,757 shares worth $1.21M. The position accounts for 0.73% of the portfolio, ranked #26.

Tower Trust & Investment Company first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Tower Trust & Investment Company held 4,757 shares of Johnson & Johnson worth $1.21M as of Q2 2026.
  • Tower Trust & Investment Company sold 5 Johnson & Johnson shares in Q2 2026, an estimated $1.17K.
  • Johnson & Johnson made up 0.73% of Tower Trust & Investment Company's portfolio in Q2 2026, its #26 holding.
  • Tower Trust & Investment Company first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.